Delivery Order SPE2DB22D2211-SPE2DB25FSFXS
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $1.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $1,271.85 firm fixed price delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/ml ampules, with an ultimate completion date of September 17, 2025. This non-set-aside contract represents a small-value pharmaceutical procurement delivered to the place of performance in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp fulfills this order under its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Hemabate 250 micrograms per milliliter in ampule form. This firm fixed-price delivery order, valued at $2,119.75, is non-set-aside and scheduled for completion by September 29, 2025. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical in the amount of $2,374.92 to supply 250 micrograms per milliliter ampules of Hemabate. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies to be delivered by November 16, 2023. This order was awarded against an indefinite-delivery contract held by Amerisourcebergen with no set-aside designation...
- The Defense Logistics Agency awarded a $2,119.75 delivery order to AmerisourceBergen Drug Corp for Hemabate 250 mcg/mL ampules, with an ultimate completion date of September 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) designated SPE2DX with the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $7,499.25 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 250 mcg/mL ampules of Hemabate. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with completion by November 24, 2023. No set-aside designation was applied to this order, which was issued against an indefinite-delivery contract held by...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has received a $2,350.56 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to supply 4562766251 HEMABATE 250 MCG/ML AMPULML. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania by November 9, 2023. No set-aside designation was applied to this order placed pursuant to DLA Troop Support Medical's provision of pharmaceuticals and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,666.41, is for the supply of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HEMABATE 250 MCG/ML AMPULML. The award, valued at $6,555.04, is a firm fixed-price Delivery Order with a completion date of February 16, 2024. This contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the procurement of HEMABATE 250 MCG/ML AMPULML, a specialty pharmaceutical product, with a potential value of $1,097.24 and a completion date of February 1, 2024. This award is not associated with any set-aside designation....
- This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of HEMABATE 250 MCG/ML AMPULML, a pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $10,281.19 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation noted. The contract is not associated with a larger indefinite...